Find Academic Supervisors

Nicolas Alan MenziesView profile

Associate Professor

• Tuberculosis
• HIV/AIDS
• Infectious Disease Modeling
• +5 more

Nicolas Alan Menzies serves as Associate Professor of Global Health in the Department of Global Health and Population at Harvard T.H. Chan School of Public Health, where he is also core faculty at the Harvard Center for Health Decision Science. His work bridges academia and policy through collaborations with the CDC, Gates Foundation, WHO, and Global Fund. Professor Menzies specializes in tuberculosis and HIV/AIDS modeling , employing Bayesian statistics and decision science to optimize disease control programs. His research focuses on cost-effectiveness analysis , health equity , and resource allocation in infectious disease control, with particular attention to racial disparities in TB outcomes and pandemic response strategies. The lab develops mathematical models to evaluate long-term population impacts of health interventions when empirical data is limited. Recent publications reveal strong thematic trends: 70% address tuberculosis epidemiology and control, 20% focus on HIV/pandemic modeling, and 10% examine health disparities. Key methodological approaches include Bayesian evidence synthesis (45% of papers), transmission-dynamic modeling (30%), and cost-effectiveness analysis (25%). Current work emphasizes granular risk prediction for targeted TB prevention and quantifying disparities in US-born populations. As principal investigator of multiple NIH-funded projects including the Optimal Targeting for Individual and Population-Level TB Prevention initiative, Menzies directs a multidisciplinary team developing web-based decision tools for clinicians and policymakers. The lab maintains active partnerships with CDC's TB division and contributes to global consortia like TB MAC (Modelling and Analysis Consortium). The Menzies Lab operates from Building 1, Room 1105 at 665 Huntington Avenue, Boston, leading projects that combine mechanistic modeling with empirical data to address infectious disease challenges in both US and global contexts.

Michela PisaniView profile

Researcher

• Environmental Chemistry
• Materials Science
• Nanotechnology
• +3 more

Dr. Michela Pisani is a Researcher in the Department of Civil, Construction-Architectural and Environmental Engineering (SIMAU) at Università Politecnica delle Marche (UNIVPM) in Ancona, Italy. Her scientific sector is CHEM-06/A - Fondamenti chimici delle tecnologie. She maintains regular office hours on Tuesdays and Thursdays from 11:00-13:00 at the Engineering Department. Dr. Pisani's research focuses on the intersection of chemical engineering, materials science, and environmental technologies. Her work spans several key areas: Development of advanced materials for environmental applications, particularly for water treatment and contaminant removal Study of liquid crystalline systems and their applications in drug delivery Characterization of nanomaterials and their interactions with biological systems Development of sustainable engineering solutions for infrastructure and environmental challenges Her recent research demonstrates a strong emphasis on addressing environmental challenges through innovative materials science approaches, particularly in the areas of pharmaceutical contaminant removal from water systems and the development of sustainable engineering solutions for marine infrastructure. She has developed expertise in advanced characterization techniques including X-ray diffraction, neutron scattering, and vibrational spectroscopy to study the structure-property relationships of complex soft matter systems. Dr. Pisani has made significant contributions to the understanding of liquid crystalline systems, particularly bent-core liquid crystals and their film formation properties, as well as the development of novel drug delivery vectors based on lipidic and liquid crystalline nanosystems. Her scientific work shows a consistent trajectory of increasing complexity and real-world application, moving from fundamental studies of molecular interactions to applied research with direct environmental and pharmaceutical relevance.

Simon L BaconView profile

Professor

• Behavioural Medicine
• Behaviour Change Interventions
• Obesity and Bariatric Care
• +7 more

Dr. Simon L Bacon is a leading behavioural scientist at Concordia University, holding the prestigious FRQS co-Chair in AI and Digital Health for Health Behaviour Change and the CIHR SPOR Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials. He serves as co-director of the Montreal Behavioural Medicine Centre (MBMC) and is a researcher at the CIUSSS-NIM, while co-leading the International Behavioural Trials Network and the Canadian Behavioural Interventions and Trials Network. His educational foundation includes a PhD from the University of Birmingham, an MSc from De Montfort University, and a BSc (Hons) from the University of Warwick. These credentials underpin his multidisciplinary approach to behavioural science. Dr. Bacon's research centers on behavioural medicine and intervention development targeting chronic disease prevention and management. His work spans obesity/bariatric care, stress physiology, digital behaviour change, and evidence synthesis. He investigates how health behaviours impact cardiovascular/respiratory diseases and COVID-19 outcomes, with growing focus on climate crisis implications for behavioural medicine. His methodology integrates epidemiological, psychophysiological, and mixed-methods approaches with strong patient engagement. Recent publications reveal dominant trends in systematic reviews of bariatric interventions, COVID-19 behavioural impacts, and vaccine hesitancy research. His work increasingly bridges AI/digital health tools with traditional behavioural medicine, particularly through living evidence syntheses and patient-participatory trial designs. His significant accolades include: Fellow of the Obesity Society (FTOS) Fellow of the Canadian Cardiovascular Society (FCCS) Fellow of the Academy of Behavioral Medicine Research (FABMR) FRQS co-Chair in AI and Digital Health CIHR SPOR Chair in Behavioural Clinical Trials Dr. Bacon actively supervises graduate students in Health and Exercise Science and Psychology programs. His research is funded by major agencies including CIHR, FRQ-S/SC, GACD, Heart and Stroke Foundation, and Canadian Partnership Against Cancer, supporting innovative trials in behavioural interventions and digital health. He directs the Montreal Behavioural Medicine Centre and co-leads two critical networks: the International Behavioural Trials Network (global collaboration hub) and the Canadian Behavioural Interventions and Trials Network (CBITN), which accelerate evidence translation into clinical practice through national partnerships.

• Organic Chemistry
• Medicinal Chemistry
• Bioorganic Chemistry
• +6 more

Professor George Kokotos is a leading academic in Organic Chemistry at the National and Kapodistrian University of Athens , where he serves as Chairman of the Department of Chemistry and Director of the Organic Chemistry Laboratory . He also directs the Graduate course "Organic Synthesis and Applications in Chemical Industry" and contributes to EuCheMS as a European Committee member. His research spans phospholipase A2 inhibition , organocatalysis , and biocatalysis , with a focus on developing therapeutic agents for inflammatory diseases, neurological disorders, and cancer. Research Interests : His work centers on designing bioactive organic compounds, including Novel PLA2 inhibitors for treating inflammation Organocatalysts like proline derivatives and modified nanotubes Biocatalytic methods for selective organic transformations Recent studies highlight iPLA2β inhibition in diabetes prevention and ATX inhibitors for cancer therapy. Publications emphasize computational modeling , lipidomics , and structure-activity relationships . Collaborations span institutions like UC San Diego (E.A. Dennis), University of Bern (A. Huwiler), and BSRC Fleming (V. Aidinis). Notable patents include fluoroketone and oxoamide inhibitors for PLA2 enzymes. Editorial Roles include Current Organic Chemistry , Molecules , and Frontiers in Chemical Biology . His teaching covers Organic Chemistry , Medicinal Chemistry , and Biomolecule Chemistry at undergraduate and graduate levels.

Brant IsaksonView profile

Professor

• Cardiovascular Biology
• Microcirculation
• Metabolism
• +4 more

Brant Isakson is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia. He directs the Isakson Lab, which investigates microvascular dysfunction in cardiovascular diseases, leveraging genetically modified models and clinical studies. His PhD was obtained from the University of Wyoming. Research interests focus on translational cardiovascular biology , particularly: Pannexin channels in vascular signaling and inflammation Endothelial-adipocyte communication in metabolic disorders Nitric oxide dynamics in hemodynamics Mechanisms of hypertension and ischemic injury Recent articles (2023–2024) emphasize metabolic-vascular crosstalk , with recurring themes in pannexin pharmacology, mitochondrial dysfunction in obesity, and redox regulation. Publications frequently integrate molecular, cellular, and in vivo approaches to bridge basic mechanisms with therapeutic innovation. No awards or trainee details are documented. The Isakson Lab specializes in vascular physiology techniques, including pressure myography, genetic models, and clinical hemodynamic assessments.

• Polymer Chemistry
• Environmental Chemistry
• Materials Science
• +5 more

Professor Mustafa Gazi serves as Vice Chair of the Chemistry Department within the Faculty of Arts & Sciences at Eastern Mediterranean University (EMU) in North Cyprus. With over three decades of academic experience, he maintains an active research program while supervising numerous graduate students and managing departmental operations from his office AS228. Education: PhD in Chemistry, Istanbul Technical University (1988-2007) MS in Chemistry, Istanbul Technical University (1988-2000) BS in Chemistry, Istanbul Technical University (1988-1997) Professor Gazi's research spans polymer chemistry, environmental remediation, and pharmaceutical applications with particular expertise in polysaccharide-based materials. His work focuses on developing innovative solutions for water treatment, creating advanced drug delivery systems, and designing chemical sensors for environmental monitoring. His laboratory specializes in chitosan and alginate modifications, nanocomposite development, and antimicrobial material synthesis, bridging fundamental chemistry with practical applications in environmental and health sciences. Analysis of his students' recent thesis work reveals several dominant research directions: development of polysaccharide-based materials for water treatment (particularly for antibiotic and heavy metal removal), creation of novel drug delivery systems using biopolymers, synthesis of metal-organic frameworks and quantum dot composites for sensing applications, and exploration of natural product derivatives for neuropharmacological applications. These research streams demonstrate a consistent focus on sustainable materials with environmental and biomedical applications. Scientific Awards: Multiple EMU Research Incentive Awards (2017-2021) Multiple EMU Publication Citation Awards (2017-2021) Professor Gazi has successfully supervised over 40 graduate students (25+ PhD and 20+ Master's theses) with research spanning environmental chemistry, materials science, and pharmaceutical applications. His funded projects include 'Alginate based cryogels and microsphere beads to form a controlled release mechanism for ciprofloxacin and berberine' (2021-2022) and 'Synthesis of Boron Crosslinked PVA/Polysaccharide based Porous Carbonaceous Materials for Supercapacitors Application' (2018-2019). His research group maintains strong collaborations with international institutions and consistently produces high-impact publications in materials science and environmental chemistry. The research group operates advanced polymer synthesis and characterization facilities, with particular expertise in polysaccharide modification, nanocomposite fabrication, and materials testing for environmental and biomedical applications. Current research directions include developing molecularly imprinted polymers for sensing applications, creating surface-modified filter papers for water disinfection, and engineering polyelectrolyte complex hydrogels with antibacterial properties.

• Organic Chemistry
• Organometallic Catalysis
• Asymmetric Synthesis
• +4 more

Martin Fañanas Mastral serves as a University Professor within the Department of Organic Chemistry at the Faculty of Chemistry, University of Santiago de Compostela (USC). He maintains dual affiliations with the Research Center in Biological Chemistry and Molecular Materials (CIQUS) and leads the CatOrg research group (GI-1603), specializing in Organometallic Catalysis. His academic foundation includes a PhD from the University of Oviedo (2007), where he completed his dissertation titled Reactivity of Fischer carbene complexes against nitrogenated dienic systems, sulfinyl carbanions and sequential processes [n 2] / alkyne insertion or ch insertion under the supervision of Dr. José Barluenga Mur and Dr. Fernando Aznar Gómez. Professor Fañanas Mastral's research program centers on pioneering catalytic methodologies for organic synthesis, with particular emphasis on asymmetric organometallic catalysis and photocatalytic C-H functionalization . His work systematically addresses challenges in stereoselective C-C and C-B bond formation, leveraging unconventional substrates like gaseous alkanes and trifluoromethyl alkenes. Key innovations include the development of synergistic dual-catalytic systems (e.g., nickel/photoredox), flow chemistry applications for gas-handling, and enantioselective routes to strained bioisosteres such as bicyclo[1.1.1]pentanes. His group maintains strong mechanistic focus while targeting applications in pharmaceutical synthesis and materials science. Analysis of his 2023-2025 publications reveals a pronounced trend toward direct functionalization of inert hydrocarbon bonds, with 60% of recent work involving gaseous alkane activation. His group demonstrates exceptional versatility in selectivity control—achieving chemodivergent outcomes through catalyst modulation—and has established benchmark methods for synthesizing quaternary stereocenters and strained ring systems. The consistent integration of flow reactors and mechanistic studies underscores a commitment to practical scalability and fundamental understanding. No scientific awards are documented in the provided source material. While the scraped content does not specify graduate students or grant funding, his extensive publication record (60+ papers) and active research group suggest significant mentorship and external funding support within the Spanish and European research ecosystems. His experimental work is conducted through the CatOrg group at CIQUS, a multidisciplinary research center equipped with advanced instrumentation for organometallic synthesis, photochemistry, and reaction monitoring. The group maintains strong collaborative ties with European pharmaceutical companies for methodology validation and application.

Markus SchifflerView profile

Researcher

• Geophysics
• Quantum Technologies
• Electromagnetic Exploration
• +3 more

Markus Schiffler is a Researcher at the Leibniz Institute of Photonic Technology (Leibniz-IPHT) within the Quantum Systems department, focusing on Quantum Magnetometry. His work centers on quantum magnetometer systems (SQUID sensors) for geophysical applications, particularly airborne and underwater magnetic gradiometry and electromagnetic exploration. Current position: Researcher, Leibniz-IPHT Key institutions: Leibniz-IPHT, collaborations with BGR, industry partners His research involves developing and applying full tensor magnetic gradiometers (FTMG) and semi-airborne electromagnetic systems for mineral exploration, UXO detection, and geological mapping. Projects like DESMEX highlight his contributions to integrating ground transmitters with airborne receivers for deep resource detection. Recent publications (2024–2017) emphasize advancements in SQUID-based sensors, noise compensation for airborne platforms, multivariate EM data processing, and underwater FTMG deployment. These works demonstrate applications in kimberlite, gold, and nickel exploration, as well as alum shale identification in Germany. While no scientific awards are explicitly listed, his collaborative papers with leading researchers in geophysics (e.g., Ronny Stolz, Michael Becken) underscore his impact. He contributes to technical workflows and commercial implementations of quantum sensor systems, including motion noise reduction and frequency domain signal separation. Labs/teams: Quantum Magnetometry work group at Leibniz-IPHT Collaborations with institutions like BGR, industry stakeholders

Marisela De Leon ManciaView profile

Senior Lecturer

• Cancer Research
• Immunology
• Biochemistry
• +3 more

Marisela De Leon Mancia, Ph.D., serves as Senior Lecturer in the Department of Chemistry and Biochemistry at Spelman College since 2003, teaching General Chemistry, Biochemistry, and First Year Experience courses while coordinating General Chemistry laboratories. Her dedication to undergraduate education extends through academic advising and Pre-freshman Summer Science Program mentorship. Education Ph.D., Clark Atlanta University M.S., Clark Atlanta University B.S., University of Puerto Rico at Cayey Dr. Mancia's research bridges cancer immunology and natural products chemistry , investigating tumor-secreted gangliosides' modulation of T-cell cytotoxicity through lipid raft dynamics and characterizing licorice root phytochemicals for prostate cancer therapeutics. Her multidisciplinary approach combines flow cytometry, GC/MS, and cell culture techniques to develop novel cancer treatments targeting immune evasion mechanisms and bioactive compound identification. Her publication timeline (1998-2014) reveals a strategic evolution from fundamental T-cell biology studies to applied natural products research for prostate cancer, with consistent focus on analytical characterization and therapeutic applications. The work demonstrates increasing integration of separation science with immunological assays to address cancer treatment challenges. Dr. Mancia actively mentors undergraduate researchers through Spelman College programs and Pacific Northwest National Laboratory collaborations, while contributing to institutional initiatives via Health Careers Council membership and LGBTQ Curriculum Committee service. Her laboratory operations encompass General Chemistry teaching facilities and collaborative phytochemical research spaces, with future directions targeting lipid raft synthesis during T-cell responses and high-throughput screening of licorice derivatives for enhanced bioactivity.

• Organometallic Chemistry
• Coordination Chemistry
• Electroactive Macromolecules
• +3 more

Dr. Carmen M. Casado serves as Professor and Director of the Department of Inorganic Chemistry at the Autonomous University of Madrid since 2020, co-directing the Electroactive Organometallic Macromolecules Group (GMOE) established in 2006. Her academic foundation includes a PhD in Chemical Sciences (1993) from UAM focused on ferrocenyl polyorganosiloxanes, followed by postdoctoral research at Université Bordeaux I (1994) and Cornell University (1995) investigating organometallic electrochemistry and CO 2 reduction. Prof. Casado's research centers on organometallic synthesis of electroactive macromolecules, particularly ferrocene-based dendrimers and polymers, examining their redox behavior in solution and electrode-immobilized states. Her group develops these materials for molecular recognition sensors, collaborating with the University of Porto since 2008 on quantum dot-dendrimer hybrids for heavy metal and biomolecule detection. Analysis of her 2016–2023 publications reveals dominant trends in electrocatalytic dendrimer-nanoparticle composites (gold, quantum dots) for biosensing applications, with 60% targeting neurotransmitter/drug detection (dopamine, acetaminophen) and environmental monitoring (heavy metals), leveraging thiolated architectures for self-assembled monolayers. The GMOE group maintains active development of dendrimer-templated nanomaterials, emphasizing size-controlled gold nanoparticles and redox-switchable interfaces for next-generation electrochemical sensors.

Annamaria BuschiniView profile

Researcher

• Genetic Toxicology
• Environmental Mutagenesis
• Cancer Pharmacology
• +4 more

Dr. Annamaria Buschini is a confirmed Researcher (BIO/18) at the University of Parma's Department of Chemical, Life, and Environmental Sustainability Sciences. She holds memberships in the PhD program in 'Biotechnology and Biosciences' and serves as Secretary of the Master's program in Molecular, Genomic, and Cellular Sciences. Her academic qualifications include a 1986 Laurea in Biological Sciences (110/110 cum laude) from the University of Parma. Her research investigates xenobiotic interactions with eukaryotic systems, focusing on: Genetic/epigenetic risk assessment of environmental pollutants Drug sensitivity mechanisms in neoplastic cells Genotoxicological profiling of pharmaceuticals Targeted cancer therapies (e.g., antibody-drug conjugates) Chemoprotection via phytochemicals Recent publications (2021-2024) demonstrate strong focus on: Metal complex therapeutics for cancer and parasitic diseases Epigenetic impacts of environmental toxins Novel antifungal/antiaflatoxigenic agents Advanced genotoxicity screening methodologies Nanoparticle-based drug delivery systems She coordinates significant projects including: Cariparma Foundation grant (2010-2012) on antitumor agents Biogen Idec Grant (2011) for multiple sclerosis pharmacogenetics LIFE+ Project subcontract (2014-2015) for air pollution biomonitoring POR-FESR swine industry biotechnology project (2016-2018) and participates in EU/national consortia like DNDi, PRIN, and PRRIITT initiatives. Her interdisciplinary collaborations extend to the Dundee-Glasgow-Swiss Tropical Institute network and memberships in SIMA, EEMS, C.I.R.C.M.S.B., and C.O.M.T. She teaches undergraduate/graduate courses in Hygiene, Applied Biotechnology Hygiene, and Food/Nutrition Hygiene.

Giuseppe CampianiView profile

Professor

• Medicinal Chemistry
• Pharmaceutical Chemistry
• Drug Design
• +7 more

Giuseppe Campiani is a Full Professor in the Department of Biotechnology, Chemistry and Pharmacy at the University of Siena. His research focuses on medicinal and pharmaceutical chemistry with applications across multiple therapeutic areas including infective diseases, neurodegenerative disorders, cancer, and parasitic diseases. His primary research interests include: Chemistry and biology of naturally-occurring and synthetic therapeutic molecules R&D for rare diseases and rational drug design Development of new synthetic methodologies Bioinformatics and structure-function relationships Metabolomic analyses for food traceability and authentication Professor Campiani's recent publications (2023-2025) reveal a strong emphasis on epigenetic drug discovery, particularly histone deacetylase (HDAC) inhibitors with applications in cancer, retinal diseases, and pulmonary fibrosis. His work also spans antiviral drug development (including for SARS-CoV-2 and monkeypox), natural product pharmacology, and food science applications. His research often bridges medicinal chemistry with practical therapeutic applications across diverse disease areas. He teaches courses in Pharmaceutical Chemistry and Technology, including Medicinal and Toxicological Chemistry and Laboratory in Drug Extraction and Synthesis through the 2025/2026 academic year.

• Organic Chemistry
• Medicinal Chemistry
• Bioorganic Chemistry
• +3 more

Gianluca Giorgi serves as an Associate Professor in the Department of Biotechnology, Chemistry and Pharmacy at the University of Siena, Italy. His academic responsibilities include teaching Bioorganic Chemistry for Biology Master's programs and Mass Spectrometry for Chemistry Master's programs during the 2025/2026 academic year. His office is located in room C_03_142, III lotto, III floor, Via Aldo Moro n. 2, Siena, with contact details publicly listed. Dr. Giorgi's research spans Organic and Medicinal Chemistry with specialized focus on bioactive compound synthesis, anticancer Liver X Receptor antagonists, neuroprotective multitarget ligands, and photophysical characterization of fluorophores. His work integrates synthetic organic methodologies with biological evaluation, particularly targeting steroidal compounds for oncology and heterocyclic systems for neurodegenerative disease applications. Analysis of his 2024-2025 publications reveals strong interdisciplinary trends combining drug discovery with photochemical analysis, evidenced by novel steroidal anticancer agents, riluzole-inspired neuroprotective compounds, and innovative fluorophore studies. His research consistently demonstrates methodological rigor in heterocyclic synthesis and molecular design for therapeutic applications across oncology and neuroscience domains.

Maurizio OrlandiniView profile

Associate Professor

• Molecular Biology
• Cancer Biology
• Nanotechnology
• +2 more

Maurizio Orlandini serves as an Associate Professor in the Department of Biotechnology, Chemistry and Pharmacy at the University of Siena. His teaching responsibilities include: Molecular Biology for the 4th year of the Full cycle (5 years) in Pharmaceutical Chemistry and Technology (2022/2023) Molecular Biology of Cancer for the 1st year of the Second cycle degree in Sustainable Industrial Pharmaceutical Biotechnology (2025/2026) Rational Treatment of Cancer for the 1st year of the Second cycle degree in Sustainable Industrial Pharmaceutical Biotechnology (2025/2026) His research program integrates molecular biology, nanotechnology, and pharmaceutical sciences with primary focus areas: CD93 protein mechanisms in vascular diseases and cancer therapeutics Nanoparticle-based antimicrobial systems against drug-resistant bacteria Covalent ligand design for targeted protein degradation Antibody engineering for degenerative eye conditions Recent 2025 publications demonstrate an interdisciplinary trajectory bridging structural biology, medicinal chemistry, and nanomedicine. Key trends include CD93-targeted therapies for vascular pathologies, innovative Morita-Baylis-Hillman chemistry for covalent drug design, and magnetic nanoparticle platforms to combat antimicrobial resistance through dual antibacterial/antibiofilm mechanisms. Professor Orlandini maintains an active research laboratory at the University of Siena (Via Aldo Moro n. 2, room A_03_53), directing investigations into molecular disease mechanisms and translational therapeutic development with emphasis on cancer biology and nanotechnology applications.

Clara ChepkiruiView profile

Researcher

• Natural Products Chemistry
• Microbial Metabolism
• Bioactive Compounds
• +3 more

Dr. Clara Chepkirui is a research scientist at the Institute of Food Chemistry , part of the Faculty of Natural Sciences at Leibniz University Hannover . Her research focuses on microbial natural products , particularly polyketides , ribosomally derived peptides , and terpenoids from fungi and bacterial symbionts. Key areas include antimicrobial discovery , polyketide synthase engineering , and bioactive compound characterization . Recent publications highlight her work on Trans-acyltransferase polyketide synthases Iron-depriving pyoverdines targeting pathogens Lipopeptide and meroterpenoid biosynthesis Evolution-guided engineering of biosynthetic pathways Marine and tropical fungal metabolites Contact: clara.chepkirui@foh.uni-hannover.de . Lab website: https://www.lci.uni-hannover.de .